- OKP 1H FY26 net profit rises 43.8% to S$27.3 million; revenue climbs 9% to S$113.8 million
- SIMON PROPERTY GROUP INC <SPG.N>: STIFEL RAISES TARGET PRICE TO $209 FROM $194
- REVOLUTION MEDICINES, INC. <RVMD.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $231 FROM $210
- BlackRock lifts LEG Immobilien voting rights to 10.04% from 10%
- RAPID7, INC. <RPD.O>: STIFEL RAISES TARGET PRICE TO $13 FROM $7
- Deutsche Bank economists anticipate that U.S. gasoline prices will fall by about 2% in July, with both headline and core CPI year-on-year growth rates dropping by approximately 0.1%. The former is expected to decrease from 3.53% to 3.45%, and the latter from 2.59% to 2.51%.
- HINGE HEALTH, INC. <HNGE.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $112 FROM $85
- ALAMAR BIOSCIENCES INC : STIFEL RAISES TARGET PRICE TO $32 FROM $28
- ASTRANA HEALTH, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $55 FROM $47
- Brent crude oil fell by about $1 in the short term, hitting a low of $87.17 per barrel.
- The main contract of Nymex WTI crude oil futures just broke through the $82.00 per barrel mark, last quoted at $81.98 per barrel, down 0.18% on the day.
- REVOLUTION MEDICINES, INC. <RVMD.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $231 FROM $210
- Eltek director Amit Foox files initial beneficial ownership statement
- Neo Q2 FY26 adjusted EBITDA more than doubled to USD 57.03 million; revenue rises to USD 205.75 million
- Aasen Sparebank mulls NOK 50 million subordinated bond issue
- US Dollar Index Price Forecast: A break above 100.00 would confirm a double bottom
- Polar Power receives orders for 15 solar hybrid power systems in Solomon Islands
- HINGE HEALTH, INC. <HNGE.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $112 FROM $85
- Superior Group amends, extends $200 million credit facilities with PNC-led lender group to 2031
- Kim Heng expects net loss for HY2026 amid weaker geotechnical survey, vessel trading revenue
- ASTRANA HEALTH, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $55 FROM $47
- Correct: Pet Valu Holdings 2Q EPS C$0.37 >PET.T
- Knowit names Fredrik Ekerhovd CEO effective immediately
- Green Thumb publishes investor presentation on U.S. THC market growth, category leadership strategy
- BEST BUY CO., INC. <BBY.N>: TRUIST SECURITIES RAISES TO BUY FROM HOLD; RAISES TARGET PRICE TO $95 FROM $81
- Correct: Pet Valu Holdings 2Q Rev C$290.7M >PET.T
- Milady memecoin whales sitting on paper profits worth more than $20 million
- How 4.3 million crypto investors lost $46 billion in just five months — told in charts
- Bitcoin active users plummet even as transactions rise
- Solana sees surge in new users amid higher fees on Ethereum, Bitcoin
- Celsius moves $780 million in stETH as Lido Finance enables withdrawals
- ABCELLERA BIOLOGICS INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $30 FROM $12
- VinFast (VFS.US): According to the agreement, as part of SpaceX’s rideshare program, the company's satellites will be launched aboard a transport spacecraft in 2027.
- Spot gold just reached the $4,390.00/ounce mark, last quoted at $4,390.14/ounce, unchanged on the day; the main COMEX gold futures contract was last quoted at $4,447.70/ounce, up 0.63% on the day.
- The main contract of Nymex crude oil futures has just surpassed the $83.00 per barrel mark, now quoted at $82.98 per barrel, up 1.03% on the day.
- The main Brent crude oil futures contract has just surpassed the $88.00 per barrel mark, now quoted at $87.99 per barrel, up 0.19% on the day; the main US unleaded gasoline futures contract has just surpassed the $3.1400 per gallon mark, now quoted at $3.1391 per gallon, up 0.12% on the day.
- Vestis Q3 revenue misses estimates on lower volumes
- Middleby Sees FY26 Adj EPS $6.73-Adj EPS $6.89 >MIDD
- Hub Group delays Q2 10-Q filing as it restates prior financial statements
- Middleby Sees 3Q Adj EPS $1.67-Adj EPS $1.83 >MIDD
- Middleby Sees FY26 Sales $2.48B-$2.53B >MIDD
- Harvard Bioscience Sees 2026 Revenue Growth of 3% to 5% >HBIO
- Middleby Sees 3Q Sales $620M-$640M >MIDD
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- Janus International posts investor presentation outlining self-storage and commercial building solutions strategy
- Harvard Bioscience raises FY2026 revenue growth outlook to 3%-5%
- Yangzijiang Maritime 1H26 net profit drops 29% to US$44.9 million; total income rises 49% to US$81.6 million
- CalciMedica Q2 FY26 net loss widens to $7.65 million
- Legend Biotech Q2 FY26 turns to net income of $33.2 million; revenue rises 51.9% to $387.5 million year over year
- Goldman Sachs cuts Scout24 voting rights to 5.48% from 6.24%
- Ashley Gold concludes Phase III drilling at Tak project, flags new gossan target northwest of NTZ
- Fennec swings to FY26 Q2 net income of $1.97 million; net sales rise 78% to $17.1 million year over year
- Blue Moon Metals posts corporate presentation on advancing US, Norway critical metals projects toward production
- Stellar AfricaGold finalizes 5,000-meter Phase II drill targets at Tichka Est gold project in Morocco
- Sono-Tek receives record order worth over $3.6 million for integrated production line
- QuantumCore closes C$4.69 million private placement at C$2 per share
- Arya Resources acquires 100% of Wedge Lake Gold Project, issues 500,000 shares and pays $30,000
- Chicago Atlantic Real Estate Finance Q2 FY26 net income falls 16% to $7.47 million; revenue dips 8% to $15.22 million
- CenterPoint Energy projects $5 billion Texas customer savings from large-load growth initiative
- CVRx CRO Robert John exits; Paul Verrastro named interim head of sales
- West Point Gold drills 7.6 m at 2.22 g/t gold at Black Dyke prospect, Arizona Gold Chain project
- Neo Performance Materials Raises Full-Year Adjusted EBITDA Guidance to $140M-$150M >NEO.T
- C4 Therapeutics 2Q Loss $23.6M >CCCC
- CVRx Says Verrastro Has More Than 30 Years of Medical Device Sales, Marketing Experience >CVRX
- Terrestrial Energy Reported 2Q Cash Burn of $6.4M, a Decrease of $1.5M Compared to 1Q >IMSR
- Laramide Resources prices 8,350,000-share private placement at $0.60 for $5.01 million gross proceeds
- 1911 Gold updates Ogama-Rockland resource estimate, reports 712,000 oz inferred at 6.68 g/t Au
- NeurAxis Q2 net loss widens 23.4% to $2.09 million year over year; net sales more than double to $1.93 million year over year
- Upstream Bio Q2 FY26 net loss narrows 0.66% to $39.7 million
- Prelude Therapeutics Q2 FY26 net loss narrows to $13.92 million; revenue turns to $5.7 million
- Veeva says Eli Lilly commits to Vault CRM rollout globally
- PATRICK INDUSTRIES, INC. : BENCHMARK CUTS TARGET PRICE TO $115 FROM $135
- Broadwind Q2 FY26 GAAP loss from continuing operations narrows to $0.7 million; revenue rises 67% to $24.3 million
- Endurance Gold reports 9.27 g/t gold over 6.1 m in down-dip Eagle Zone extension at Reliance project
- Excalibur Metals flags new silver-gold soil anomalies at Bellehelen project in Nevada
- Aura Biosciences Q2 FY26 net loss widens to $45.64 million; R&D expense rises to $30.75 million
- Gain Therapeutics 2Q Research and Development Expenses $2.1M >GANX
- Neo Performance Materials 2Q Adj EPS 51c >NEO.T
- Vestis 3Q Rev $661.7M >VSTS
- Neo Performance Materials 2Q EPS 38c >NEO.T
- Terrestrial Energy Ended 2Q With $283.4M in Cash, Cash Equivalents and Investments >IMSR
- Harvard Bioscience 2Q Loss/Shr 64c >HBIO
- Legend Biotech 2Q EPS 9c >LEGN
- Broadwind Had Liquidity at June 30 of $40.1M >BWEN
- CVRx: Robert John, Chief Rev Officer, Will Depart Co >CVRX
- Legend Biotech 2Q Research and Development Expenses $96.0M >LEGN
- Harvard Bioscience 2Q Adj Loss/Shr 14c >HBIO
- Harvard Bioscience 2Q Loss $2.91M >HBIO
- Xtant Medical Holdings 2Q Loss/Shr 7c >XTNT
- Middleby 2Q Sales $875.5M >MIDD
- Middleby 2Q Adj EPS $2.35 >MIDD
- Middleby 2Q EPS $1.21 >MIDD
- Broadwind 2Q Rev $24.3M >BWEN
- Beyond Meat: Reverse Stk Split Intended to Help Co Regain Compliance With Minimum Bid Price Requirement for Continued Listing on Nasdaq Global Select Market >BYND
- Beyond Meat Announces 1-For-30 Reverse Stk Split >BYND
- Enviri 2Q Loss/Shr $14.21 >NVRI
- Enviri 2Q Loss $394.5M >NVRI
